Singapore General Hospital:
World's 3rd Best Hospital By Newsweek Magazine

Magazine cites hospital's clinical research and "outstanding nursing"

Singapore General Hospital (SGH) has been ranked the third best hospital in the world by Newsweek magazine, in part for its clinical research and "outstanding nursing".

It comes behind two American hospitals, the Mayo Clinic and Cleveland Clinic. The magazine said SGH, as a tertiary referral hospital with ancillary on-campus specialist centres, "provides affordable care for patients, leads patient-driven clinical research and provides undergraduate to postgraduate educational training for both students and medical professionals".

SGH was also cited as having "the island nation's largest health system, serving more than one million patients annually."

Professor Kenneth Kwek, SGH's Chief Executive Officer, said: "We are humbled to be recognised for our medical and nursing care." SGH, he said, has a strong tradition of working to improve the outcomes of patients through integrated clinical practice, innovation, cutting-edge research and new models of care.

"Our staff are passionate about healthcare and we continually challenge ourselves to do better for our patients, their family members and our staff." he added.

Of the 10 top hospitals chosen by the magazine's panel of doctors, medical professionals and administrators on four continents, four are from the United States. The only other hospital in Asia to make the list is the University of Tokyo Hospital, in eighth place. The hospital opened the trail-blazing Department of Disaster Medical Management, said the magazine.

Currently, over 400 hereditary cancer susceptibility syndromes have been described, most of which feature an autosomal dominant inheritance pattern. Although many of these are rare syndromes, they account for at least 5% - 10% of all cancer incidences. Read more.

Patients with abnormal heart rhythms now have a less invasive option to prevent sudden cardiac death. Introduced by doctors at the Department of Cardiology and Electrophysiology and Pacing service at the National Heart Centre Singapore (NHCS), SingHealth, the Subcutaneous Implantable Cardioverter Defibrillator system (S-ICD) lowers the risk of lead-related infections in or near the heart.

As an x-ray is not required, radiation exposure is also reduced. Patients on dialysis, who used to be unsuitable candidates due to a higher risk of infections and limited access to their heart and veins, are also potential candidates for the S-ICD. Read more.